Digital Health Startups

Pediatrics Plus provides pediatric therapy services and preschool programs for children, operating multiple locations across Arkansas. The company offers occupational, physical, and speech therapy alongside developmental preschool care.

2 investors

Penda Health operates a network of medical centers in Nairobi providing outpatient, home-based, specialist, and diagnostic care, along with telemedicine, to patients and corporate partners. It offers wellness packages and capitation-based plans for employers and accepts most insurance plans, positioning itself as one of the largest outpatient healthcare providers in East Africa.

2 investors

PeraHealth offers the Rothman Index, an FDA-cleared AI predictive analytics system that extracts and analyzes clinical measurements from the EMR to detect patient deterioration early and produce an aggregated score of a patient's physiological condition. It is used by clinicians in hospitals—including medical/surgical, intermediate, and intensive care units, with a pediatric variant—to guide care escalation, safe downgrades, and discharge readiness decisions.

2 investors

Perceiv is building digital infrastructure to support the delivery of neurological treatments, beginning with Alzheimer's disease, aiming to give patients access to new medical therapies. It operates in the med-tech and digital health space.

2 investors

Perceptic builds an AI platform that unifies evidence, data, and decision workflows across the drug development lifecycle, connecting asset scouting, scientific evaluation, and clinical data on a shared intelligence layer. It targets pharmaceutical and drug development organizations, providing traceable, data-backed decision-making with AI-assisted reasoning.

2 investors

Perception Medicine develops AI-driven precision oncology solutions for cancer patients. The company's team combines expertise in artificial intelligence, clinical medicine, and product design, with roots in Stanford and MIT research.

2 investors

Perception Neuroscience is a clinical-stage biotech developing R-ketamine (PCN-101), a single-isomer glutamatergic modulator being studied as a rapid-acting antidepressant for patients with treatment-resistant depression. The company licenses intellectual property originally discovered at Chiba University and is running a Phase 2a proof-of-concept clinical trial.

2 investors

Perci Health provides clinician-led cancer care and support services, serving people living with cancer and their employers through evidence-based guidance and specialist consultation. The company operates in the UK and focuses on comprehensive care for cancer patients beyond immediate treatment.

2 investors

PerfectServe provides communication and coordination software for healthcare organizations, including secure messaging, patient engagement, case scheduling, and emergency notification capabilities for hospital operations and call centers.

2 investors

Perimeter Medical Imaging AI develops ultra-high resolution imaging tools and AI software to help surgeons assess tumor margins during cancer surgery in real-time. The Toronto-based company aims to reduce the need for repeat surgeries by enabling surgeons to detect remaining cancer cells using proprietary Optical Coherence Tomography technology.

2 investors

Periotherapia develops antibody-based therapeutics targeting pathological periostin in the stromal environment to treat refractory diseases including cancer, diabetic retinopathy, and heart disease. The company, spun out from Osaka University, is conducting clinical trials for HER2-negative triple-negative breast cancer with support from Japan's AMED program.

2 investors

PeriVision develops the VisionOne platform, combining AI, virtual reality, and cloud technology to test and understand visual function for eye conditions such as glaucoma. Its systems target ophthalmology practices and hospitals, aiming to improve testing workflows and provide deeper clinical insight into eye diseases.

2 investors

Perspectives Health provides AI-powered clinical documentation and utilization review management for healthcare providers. The platform automates nightly chart audits, generates utilization review packets, manages documentation workflows, and tracks compliance issues for clinical teams.

2 investors

Perspectum develops digital medical technology and diagnostics using multiparametric MRI to assess and diagnose chronic systemic diseases including liver disease, long COVID, diabetes, and cancer for clinicians and patients.

2 investors

Pery is a SaaS platform that integrates behavioral health into clinical workflows by automating patient-reported outcomes, AI-driven analytics, and care coordination. It continuously monitors patients between visits and connects with EHRs to support provider decision-making for clinics offering mental health services.

2 investors

Jaan Health builds AI-driven software for medical groups, health systems, and ACOs to deliver proactive chronic disease management across their patient populations. Its platform, Phamily, helps physicians and care teams shift from reactive to proactive care while reducing administrative paperwork.

2 investors

Pharmeon operates Uw Zorg Online, a Dutch healthcare platform and app that lets patients book appointments, request repeat prescriptions, and contact their care providers online. It serves patients and healthcare providers such as general practitioner practices in the Netherlands.

2 investors

Pharmesol builds a network of AI agents that automate manual, fragmented processes across healthcare systems and workflows, aiming to make medications safer and easier for patients and clinicians. The platform handles routine operational tasks and turns interactions into insights for care teams.

2 investors

Phenomix Sciences applies data analytics and patient data to enable precision obesity medicine, aiming to guide treatment decisions for anti-obesity medications such as GLP-1s and reduce care costs. Its platform-based approach targets the healthcare market for obesity treatment.

2 investors

PhiTech is a TechBio company that develops AI-powered multi-omics diagnostic platforms for rare diseases and hereditary cancers. The company serves hospitals, laboratories, and pharmaceutical companies seeking to improve diagnosis and treatment decisions for complex genetic conditions.

2 investors

PhotoPharmics is a clinical-stage medical device company developing non-invasive, light-based photo-neuromodulation therapies for neurodegenerative disease, with a focus on Parkinson's disease. Its investigational device Celeste delivers light through the eyes at home and is being evaluated in clinical trials targeting non-motor symptoms such as sleep, fatigue, and mood.

2 investors

Phrase Health provides analytics tools for health systems to reduce unwarranted clinical variation within the electronic health record (EHR), aiming to lower costs and improve patient outcomes. Spun out of Children's Hospital of Philadelphia, its software applies quality improvement methods to clinical decision support and EHR governance for hospitals and health systems.

2 investors

PhySoft offers a SaaS clinical decision support platform that provides individualized, evidence-based dosing recommendations for tough-to-titrate and narrow therapeutic index drugs. It serves healthcare providers and organizations, integrating with existing EMRs to support precise dosing, reduce drug costs, and standardize care across patient populations.

2 investors

Pictor Diagnostics develops a proteomics platform that enables researchers, diagnostics manufacturers, clinical labs, and veterinary clinics to perform multi-marker protein testing across diverse sample types. The platform combines an affordable instrument and assays that integrate into existing lab workflows without requiring specialized equipment or training.

2 investors